Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

News Conference News TCT 2021

Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes

Yael L. Maxwell

November 09, 2021

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

News Opinion Editor's Corner TCT 2017

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Shelley Wood

November 22, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Conference News TCT 2015

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

October 13, 2015

Presentation TCT 2014

No: The Duration of DAPT with All DES Is Still Up in the Air!

Presenter: Laura Mauri

September 14, 2014

Presentation TCT 2014

Yes: The Data from Numerous Randomized Trials and Large Registries are Clear as a Bell!

Presenter: Fausto Feres

September 14, 2014

Presentation TCT 2014

TCT 3: A Randomized Comparison of Drug-Eluting vs Bare Metal Stenting in Patients with Non-ST Elevation Myocardial Infarction: Results of the ELISA-3 Angiographic Substudy

Presenter: Wouter Remkes, MD

September 14, 2014

Presentation TCT 2014

Not So Fast: Only a Hypothesis has Been Generated!

Presenter: Ajay J. Kirtane

September 14, 2014

Presentation TCT 2014

Meta-analyses Show This and Should Be Believed!

Presenter: Tullio Palmerini

September 14, 2014

Advertisement

What’s Going to Be Big at TCT 2024?

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes

More DAPT Duration Data, More Calls to Tailor to Individual Patients

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

No: The Duration of DAPT with All DES Is Still Up in the Air!

Yes: The Data from Numerous Randomized Trials and Large Registries are Clear as a Bell!

TCT 3: A Randomized Comparison of Drug-Eluting vs Bare Metal Stenting in Patients with Non-ST Elevation Myocardial Infarction: Results of the ELISA-3 Angiographic Substudy

Not So Fast: Only a Hypothesis has Been Generated!

Meta-analyses Show This and Should Be Believed!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content